Omalizumab in eosinophilic granulomatosis with polyangiitis: friend or foe? A systematic literature review.

Basta, Fabio; Mazzuca, Carmen; Nucera, Eleonora; Schiavino, Domenico; Afeltra, Antonella; Antonelli Incalzi, Raffaele

Basta, Fabio; Mazzuca, Carmen; Nucera, Eleonora; Schiavino, Domenico; Afeltra, Antonella; Antonelli Incalzi, Raffaele.

Afiliación

Basta F; Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy. fabiobasta@libero.it.
Mazzuca C; Department of Immuno-Rheumatology, Campus Bio-Medico, University of Rome, Italy.
Nucera E; Allergy Unit, Università Cattolica del Sacro Cuore, Policlinico A. Gemelli, Rome, Italy.
Schiavino D; Allergy Unit, Università Cattolica del Sacro Cuore, Policlinico A. Gemelli, Rome, Italy.
Afeltra A; Department of Immuno-Rheumatology, Campus Bio-Medico, University of Rome, Italy.
Antonelli Incalzi R; Unit of Geriatrics, Campus Bio-Medico University, Rome, Italy.

Clin Exp Rheumatol ; 38 Suppl 124(2): 214-220, 2020.

Article en En | MEDLINE | ID: mdl-32083537

Asunto(s)

Asma/terapia; Síndrome de Churg-Strauss/complicaciones; Granulomatosis con Poliangitis/complicaciones; Omalizumab/uso terapéutico; Asma/complicaciones; Humanos; Omalizumab/efectos adversos

Buscar en Google

Imprimir

XML

PubMed Links

Base de datos: MEDLINE Asunto principal: Asma / Síndrome de Churg-Strauss / Granulomatosis con Poliangitis / Omalizumab Tipo de estudio: Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Clin Exp Rheumatol Año: 2020 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links